Beta-Defensin-1 vs Polymyxin B — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human beta-defensin-1 (HBD-1) is a constitutively expressed antimicrobial peptide produced by epithelial cells of the skin, respiratory tract, and genitourinary system. Unlike inducible defensins, HBD-1 is present at steady-state levels as a component of basal innate immune defen...
Calculate Beta-Defensin-1 dose →Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →| Parameter | Beta-Defensin-1 | Polymyxin B |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | FDA Approved |
| Half-Life | Hours | 6-8 hours |
| Typical Dose | N/A (endogenous) | 15,000-25,000 units/kg/day IV |
| Frequency | Constitutive | Every 12 hours IV |
| Route | Endogenous | IV / IM / Topical / Intrathecal |
| FDA Status | Not approved | Approved (systemic Gram-negative infections) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.